Vetivex 9 (Ringers Solution for Infusion)

Riik: Suurbritannia

keel: inglise

Allikas: VMD (Veterinary Medicines Directorate)

Toimeaine:

Calcium Chloride Dihydrate, Potassium Chloride, Sodium Chloride

Saadav alates:

Dechra Limited

ATC kood:

QB05BB01

INN (Rahvusvaheline Nimetus):

Calcium Chloride Dihydrate, Potassium Chloride, Sodium Chloride

Ravimvorm:

Solution for infusion

Retsepti tüüp:

POM-V - Prescription Only Medicine – Veterinarian

Terapeutiline rühm:

Cats, Cattle, Dogs, Horses

Terapeutiline ala:

Replacement Agent

Volitamisolek:

Authorized

Loa andmise kuupäev:

1998-11-17

Toote omadused

Revised: October 2015
AN: 00686/2015
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Vetivex 9 (Ringer’s Solution for Infusion)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substances:
Sodium chloride
0.860 % w/v
Potassium chloride
0.030 % w/v
Calcium chloride dihydrate
0.033 % w/v
Approximate ionic content in millimoles per litre:
Sodium
147 mmol/l
Potassium
4 mmol/l
Calcium
2.25 mmol/l
Chloride
155.5 mmol/l
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for infusion.
Clear, colourless solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle, calves, horses, dogs and cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
This product is administered by intravenous infusion for the treatment
of dehydration in cattle,
calves, horses, dogs and cats. It may be used to correct volume
depletion resulting from
shock or gastrointestinal disease, especially where hypokalaemia is
present (e.g. in cases of
sustained vomiting).
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: October 2015
AN: 00686/2015
Page 2 of 4
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Ringer’s Solution for Infusion should be warmed to approximately 37
o
C prior to the
administration of large volumes, or if the administration rate is
high, in order to avoid
hypothermia.
This product should be used with caution in animals with cardiac or
renal impairment as
sodium overload may occur.
Maintain aseptic precautions.
Special precautions to be taken by the person administering the
veterinary medicinal product
to animals
Not applicable.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
There is a risk of thrombosis with intravenous infusion.
Excessive infusion rates can cause restlessness, moist lung sounds,
tachycardia, tachypnoea,
nasal discharge, coughing, vomiting and diarrhoea.
4.7
USE DURING PREGNANCY AND LACTATION OR LAY
Use under veterinary supervision.
4.8
INTERACTION WITH OTHER VETERINARY